In This Section

Newsroom

October 30, 2020
SARS-CoV-2 Spike Proteins Disrupt the Blood-Brain Barrier, Potentially Raising Risk of Neurological Damage in COVID-19 Patients

In new work from Temple scientists, they show that the spike proteins that extrude from SARS-CoV-2 promote inflammatory responses on the endothelial cells that form the blood-brain barrier. The study, published in the December print issue of the journal Neurobiology of Disease, is the first to show that SARS-CoV-2 spike proteins can cause this barrier to become “leaky,” potentially disrupting the delicate neural networks within the brain.
- VIEW STORY
October 28, 2020
Temple’s Hope Center for College, Community and Justice Celebrates Strategic Growth

The Hope Center for College, Community and Justice recently celebrated its second anniversary with the announcement of strategic organizational growth, five new teammates, and a new home within the Lewis Katz School of Medicine at Temple University.
- VIEW STORY
October 27, 2020
Investiture Ceremony Celebrates Five Endowed Chairs

The format of the recent investiture ceremony for five named endowed Chairs at the Lewis Katz School of Medicine may have been different, but in no way did it diminish the outpouring of appreciation for the faculty members being honored. Also notable – the fact that five Chairs were being invested together, a historic first for the School of Medicine.
- VIEW STORY
October 21, 2020
Temple Utilizing Innovative Technology to Transport “Breathing Lungs” for Transplant from Donor to Recipient

Temple University Hospital recently became the first hospital in Pennsylvania to perform a breathing lung transplant using the TransMedics Organ Care System for Lung, or OCS™ Lung, following FDA approval of the device for both standard and expanded criteria donor lungs.
- VIEW STORY
October 20, 2020
Temple Treats First Patient in Multicenter International Clinical Trial of RejuvenAir® Metered Cryospray System for Treatment of COPD with Chronic Bronchitis

Temple University Hospital has treated the first patient in a multicenter international clinical trial utilizing the RejuvenAir® System for the treatment of patients suffering from moderate to severe chronic obstructive pulmonary disease (COPD) with chronic bronchitis.
- VIEW STORY
October 19, 2020
Criteria to Predict Cytokine Storm in COVID-19 Patients Identified by Temple Researchers

Predicting which COVID-19 patients will develop cytokine storm is challenging, owing to the many variables that influence immune function. But now, in breakthrough work, Temple researchers have developed and validated predictive criteria for early identification of COVID-19 patients who are developing hyperimmune responses, raising the possibility for early therapeutic intervention.
- VIEW STORY
October 16, 2020
Alumni Office Celebrates Temple Homecoming Through Alumni-Student Connections

Although Homecoming Week 2020 looks very different than years past, the Lewis Katz School of Medicine Alumni Office is carrying the celebration on with the launch of a new program designed to bring Alumni and students together.
- VIEW STORY
October 14, 2020
Temple Researchers Take Aim at Elucidating Role of Cardiac Protein in Sepsis, Identifying Path to New Therapies with Funding from National Institute of General Medical Sciences

With the help of a new two-year $750,000 grant from the National Institute of General Medical Sciences (NIGMS), Temple researchers plan to elucidate the link between BNP and severe sepsis. The research could lead to the discovery of new therapies to increase blood pressure and improve survival in septic patients.
- VIEW STORY

Newsroom

Pages